Cognitive Assessment Tools Recommended in Geriatric Oncology Guidelines: A Rapid Review
Autor: | Jane Phillips, Kinglsey Frearson, Heather Lane, Meera Agar, Gina Tuch, Ki Yung Luo, Ek Leone Oh, Wee Kheng Soo |
---|---|
Jazyk: | angličtina |
Rok vydání: | 2021 |
Předmět: |
Gerontology
Vulnerability Review Neuropsychological Tests cognitive dysfunction/diagnosis dementia/diagnosis Cognition medical oncology/standards Neoplasms Medicine Humans 1112 Oncology and Carcinogenesis Cognitive Dysfunction Oncology & Carcinogenesis Cognitive impairment Geriatric Assessment RC254-282 Aged clinical decision-making business.industry screening Neoplasms. Tumors. Oncology. Including cancer and carcinogens Montreal Cognitive Assessment Test (assessment) aged Geriatric oncology geriatric assessment/methods Cognitive Assessment System cognition/physiology business Clock drawing test |
Zdroj: | Current Oncology Current Oncology, Vol 28, Iss 339, Pp 3987-4003 (2021) |
Popis: | Cognitive assessment is a cornerstone of geriatric care. Cognitive impairment has the potential to significantly impact multiple phases of a person’s cancer care experience. Accurately identifying this vulnerability is a challenge for many cancer care clinicians, thus the use of validated cognitive assessment tools are recommended. As international cancer guidelines for older adults recommend Geriatric Assessment (GA) which includes an evaluation of cognition, clinicians need to be familiar with the overall interpretation of the commonly used cognitive assessment tools. This rapid review investigated the cognitive assessment tools that were most frequently recommended by Geriatric Oncology guidelines: Blessed Orientation-Memory-Concentration test (BOMC), Clock Drawing Test (CDT), Mini-Cog, Mini-Mental State Examination (MMSE), Montreal Cognitive Assessment (MoCA), and Short Portable Mental Status Questionnaire (SPMSQ). A detailed appraisal of the strengths and limitations of each tool was conducted, with a focus on practical aspects of implementing cognitive assessment tools into real-world clinical settings. Finally, recommendations on choosing an assessment tool and the additional considerations beyond screening are discussed. |
Databáze: | OpenAIRE |
Externí odkaz: |